is semaglutide a small molecule Oral Small-Molecule GLP-1 Receptor Agonists:

Forty-six states and Washington, D.C., run at least one, with creative ideas focused on meeting social needs, services for people re-entering communities from the criminal justice system, and coverage expansions

When counseling patients concerned about access or cost following Medicare coverage changes, clinicians can use real-world data like this to reinforce that the therapeutic value of GLP-1s is well-documented, and that exploring alternative coverage pathways or manufacturer assistance programs is worth pursuing before discontinuing therapy

J., & Kalman, D

This mechanism of action, combined with its proven effectiveness, distinguishes Semaglutide from other medications

mSphere 10 , e0059024 (2025)